Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria
This study has been completed.
Study NCT00561171   Information provided by Speedel Pharma Ltd.
First Received: November 19, 2007   Last Updated: November 20, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypertension
Type II Diabetes Mellitus
Additional conditions recognized in this trial
Albuminuria
Diabetes Mellitus
Diabetes Mellitus, Type 2
More general conditions related to this trial
Cardiovascular Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Proteinuria
Signs and Symptoms
Urination Disorders
Urologic Diseases
Urological Manifestations
Vascular Diseases
Interventions listed in this trial
SPP635
Sponsors listed in this trial
Speedel Pharma Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services